P-ISSN 2587-2400 | E-ISSN 2587-196X
Ejmo Kapak
EJMO Volume : 6 Issue : 2 Year : 2022
Eurasian Journal of Medicine and Oncology

Volume: 6 Issue: 2 - 2022

REVIEW
Another Epidemic in the Shadow of Covid 19 Pandemic: A Review of Monkeypox
Ramazan Azim Okyay, Edip Bayrak, Erhan Kaya, Ahmet Riza Sahin, Burhan Fatih Kocyigit, Ali Muhittin Tasdogan, Akkan Avci, Hilmi Erdem Sümbül
doi: 10.14744/ejmo.2022.2022   Pages  95 -  99 
(Viewed: 2355)

Review of Immunotherapy Efficacy in Virus-associated Cancers
Zeynep Ýrem Ozay, Osman Sutcuoglu, Nuriye Ozdemir, Ozan Yazici
doi: 10.14744/ejmo.2022.86807   Pages  100 -  110 
(Viewed: 1188)

Role of lncRNA Alterations in Cervical Oncogenesis
Alan Lopes de Oliveira, Valéria Duarte de Almeida, Tauę Posada Pereira, Amanda Estevam Carvalho, Victor Sena Nogueira Wojcieszyn, Micássio F. Andrade
doi: 10.14744/ejmo.2022.74937   Pages  111 -  120 
(Viewed: 1090)

RESEARCH ARTICLE
Utility of EORTC and CUETO Scoring Models in the Estimation of Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer
Chaimae Hafidi Alaoui, Mohammed Tetou, Ilias Hassan, Meryem El Azzouzi, Hajar El Ahanidi, Abdelkarim Filali-Maltouf, Mohammed El Mzibri
doi: 10.14744/ejmo.2022.99203   Pages  121 -  129 
(Viewed: 1128)

The Incidence of Composite Lymphomas: Case Studies And disease Management
Svetlana Smirnova, Tatiana Moiseeva, Lubov Al-Radi, Yulia Sidorova, Elena Nikulina, Lubov Plastinina, Andrey Sudarikov
doi: 10.14744/ejmo.2022.14882   Pages  130 -  136 
(Viewed: 1076)

Immunohistochemical Evaluation of CD10 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma: A Cross-sectional Study
Sangeeta Patankar, Palak Khetan, Gokul Sridharan
doi: 10.14744/ejmo.2022.15830   Pages  137 -  141 
(Viewed: 906)

Structure-Based Molecular Docking Studies toward Exploring Phytoestrogen against Breast Cancer
Mirunalini Sankaran, Elancheran Ramakrishnan, Maruthanila Lenin
doi: 10.14744/ejmo.2022.43656   Pages  142 -  149 
(Viewed: 893)

Role of Inflammation in Benign Salivary Gland Tumor Etiopathogenesis: An Evaluation through the Blood Inflammatory Biomarkers
Vincenzo Abbate, Simona Barone, Giovanni Dell’Aversana Orabona, Paola Bonavolonta, Maria Rosaria Galdiero, Leonardo Cristinziano, Luca Modestino, Giorgio Laconetta, Luigi Califano
doi: 10.14744/ejmo.2022.29857   Pages  150 -  155 
(Viewed: 812)

A Multi-Molecular Fusion to Detect Transcriptomic Signature in Tissue-Specific Cancer
Suparna Saha, Saurav Mallik, Sanghamitra Bandyopadhyay
doi: 10.14744/ejmo.2022.53376   Pages  156 -  171 
(Viewed: 955)

Development of Predictive in Silico Cytotoxic Activity Model to Predict the Cytotoxicity of a Diverse Set of Colchicine Binding Site Inhibitors
Sumanta kumar Sahu, Krishna kumar Ojha, Vijay Kumar Singh
doi: 10.14744/ejmo.2022.44123   Pages  172 -  181 
(Viewed: 936)

CASE REPORT
Varicella-Zoster Virus Infection and Brivudine Therapy: Unexpected Response in Sarcoma Patient
Osman Kostek, Murat Sari, Ibrahim Vedat Bayoglu
doi: 10.14744/ejmo.2022.26330   Pages  182 -  185 
(Viewed: 777)

Pitfall in the Diagnosis of an Aggressive Adrenal Mass with Prominent Hirsutism: A Case Report
Ariadni Spyroglou, Marianna Karamanou, Athina Markou, Labrini Papanastasiou, Anastasia Dimitriadi, Vasiliki Mavroeidi, Chrysanthi Aggeli, Anna Tsonou, Theodosia Choreftaki, Denise Kolomodi, Georgios Boutzios, Georgios N. Zografos, Krystallenia Alexandraki
doi: 10.14744/ejmo.2022.12090   Pages  186 -  189 
(Viewed: 820)

LETTER TO THE EDITOR
Prevalence of MAFLD-Related Hepatocellular Carcinoma
Yu-Xian Teng, Hao-Tian Liu, Zhu-Jian Deng, Jia-Yong Su, Yi-Hau Lu, Jian-Hong Zhong
doi: 10.14744/ejmo.2022.77974   Pages  190 -  191 
(Viewed: 490)

Sarcomatoid Transformation of Chromophobe Renal Cell Carcinoma: An Unusual Pathology
Irene De La Parra, Álvaro Serrano, Roser Vives, Juan Hermida, Luis Ignacio Diez-Valladares, Jerónimo Barrera, José Antonio Cortés, Pilar González-Peramato, Ángel Gómez, Jesús Moreno
doi: 10.14744/ejmo.2022.11965   Pages  192 -  193 
(Viewed: 461)

Ejmo Scholarone

Ejmo scopus


EJMO Citations
Number of Citations: 1804
Number of Articles: 292
Accept Ratio : 18.2 %

Days from submission to final decision 26.5

EJMO NLM ID: 101720527
EJMO & EJMO